Owens Gary M's Form 4 filing
Mesa Laboratories Inc (MLAB) · filed Oct 29, 2024
- Accession no.
- 0001228924-24-000029
- Filed
- Oct 29, 2024
- Trade date
- Oct 27-29, 2024
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions. Open-market sales total $571.8K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Owens Gary MCIK 0001700671 | Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 27, 2024 | Common Stock | AGrant or awardAcquired | +11,559 | $0.00 | $0 | 48,406 | Direct | |
| Oct 28, 2024 | Common Stock | SSaleDisposed | −2,518 | $113.62 | −$286,095.16 | 45,888 | Direct | |
| Oct 29, 2024 | Common Stock | SSaleDisposed | −2,551 | $111.98 | −$285,660.98 | 43,337 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.